CIDRAP newsletters options
The shortage is leading to delays in the testing of deer samples submitted by hunters.
The UK mammal H5N1 findings include foxes and otters, part of ongoing detections in mammal species alongside outbreaks in poultry and wild birds.
Scientists have identified the Alpha, Gamma, and Delta variants in white-tailed deer well after they caused widespread COVID-19 in people.
In a related development, New York City today declared the end of its mpox outbreak, which follows 2 months of low transmission.
The estimated vaccine effectiveness of one subcutaneous dose of the Jynneos mpox vaccine among men in Israel is 86%.
The agency is probing a multistate outbreak of carbapenem-resistant Pseudomonas aeruginosa linked to eye drops, one case of vision loss, and one death.
COVID-19 cases have declined 78% worldwide over the past 28 days, but deaths rose 65% over the same period, the WHO says.
Risk factors include receiving intubation, a central venous line, or a drain, plus receipt of antifungal drugs within 7 days of admission.
The change won't immediately impact vaccine or treatment access or FDA emergency use status.
Deficits were more pronounced in math than in reading, and economically disadvantaged kids fared worse.
Despite PCR's higher sensitivity, frequent testing with rapid antigen tests can top their performance, a study of pro soccer players finds.
A meta-analysis finds that the risk of an antibiotic-resistant infection in patients colonized with drug-resistant bacteria is around 14%.
Health officials confirm 5 new cases, including 2 fatal ones, for a total of 8 infections so far this year.
Among children, COVID-19 was the eighth-leading cause of death from any cause and first in deaths caused by infectious or respiratory disease.
Deaths and struggling health systems are among ongoing concerns, and the group will likely meet again in 3 months to reassess developments.
A randomized trial in Canada finds that COVID-19 patients in the audit and feedback group had lower antibiotic use but similar outcomes to patients treated with standard of care.
The NSABB endorses findings from two of its working groups, one on oversight of potential pandemic pathogens and the other on dual-use research of concern.
Boosters lower the risk of death among adults more than 90% and increase protection against severe disease in children aged 5 to 11 years by 77%, new data reveal.
A 5-year study of US hospital data illustrates trends in E coli and Klebsiella pneumoniae isolates carrying beta-lactamase antibiotic resistance genes.
The bivalent booster offered additional benefits against symptomatic infection and severe illness, 3 new studies show.
